Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xolv is a U.S.-based health technology company focused on behavioral health and home- and community-based care, particularly for people affected by autism spectrum disorder and intellectual and developmental disabilities. The company originated from the technology organization that supported Catalight and became an independent corporation in January 2024. Xolv provides software and related technology services spanning clinical operations, clinical practice workflow, direct client engagement, revenue cycle support, enterprise IT, integrations, and data-security-enabled healthcare infrastructure. Its offerings are designed for clinicians, providers, caregivers, families, government agencies, and nonprofit or private organizations that support ASD and IDD populations. Xolv appears to operate as a commercial-stage healthcare IT and platform company rather than a therapeutics developer, so it does not have a traditional drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xolv Technology Solutions.